Should I buy or sell Chemed stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CHE shares. View CHE analyst ratings or view top-rated stocks .

What is Chemed's stock price target for 2024?

2 Wall Street research analysts have issued twelve-month price targets for Chemed's stock. Their CHE share price targets range from $650.00 to $712.00. On average, they anticipate the company's share price to reach $681.00 in the next year. This suggests a possible upside of 14.0% from the stock's current price. View analysts price targets for CHE or view top-rated stocks among Wall Street analysts .

How have CHE shares performed in 2024?

Chemed's stock was trading at $584.75 at the beginning of 2024. Since then, CHE stock has increased by 2.2% and is now trading at $597.42. View the best growth stocks for 2024 here .

When is Chemed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024. View our CHE earnings forecast .

How can I listen to Chemed's earnings call?

Chemed will be holding an earnings conference call on Thursday, April 25th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link .

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its earnings results on Tuesday, February, 27th. The company reported $6.60 earnings per share for the quarter, beating the consensus estimate of $6.25 by $0.35. The business had revenue of $585.90 million for the quarter, compared to the consensus estimate of $586.64 million. Chemed had a trailing twelve-month return on equity of 32.29% and a net margin of 12.03%. Chemed's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period last year, the business earned $5.39 earnings per share.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, February 16th. Stockholders of record on Monday, February 26th will be given a dividend of $0.40 per share on Friday, March 15th. This represents a $1.60 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date is Friday, February 23rd. Read our dividend analysis for CHE .

Is Chemed a good dividend stock?

Chemed (NYSE:CHE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.26%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.93%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 6.66% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CHE .

What ETFs hold Chemed's stock?

ETFs with the largest weight of Chemed (NYSE:CHE) stock in their portfolio include Formidable Fortress ETF (KONG) , VictoryShares THB Mid Cap ESG ETF (MDCP) , First Trust Dorsey Wright Momentum & Low Volatility ETF (DVOL) , Inspire Faithward Mid Cap Momentum ETF (GLRY) , Opus Small Cap Value Plus ETF (OSCV) , ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) , FIS Biblically Responsible Risk Managed ETF (PRAY) and ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) .

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of 23.300-23.700 for the period, compared to the consensus earnings per share estimate of 23.010. The company issued revenue guidance of -.

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com . Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T) , Home Depot (HD) , Johnson & Johnson (JNJ) , AbbVie (ABBV) , Abbott Laboratories (ABT) , CVS Health (CVS) , Boeing (BA) , UnitedHealth Group (UNH) , Verizon Communications (VZ) and Chevron (CVX) .

Who are Chemed's major shareholders?

Chemed's stock is owned by many different institutional and retail investors. Top institutional investors include Los Angeles Capital Management LLC (0.28%), Capital Insight Partners LLC (0.07%), MJP Associates Inc. ADV (0.01%), Wealth Enhancement Advisory Services LLC (0.01%), Ausbil Investment Management Ltd (0.01%) and LVW Advisors LLC (0.01%). Insiders that own company stock include Brian C Judkins, David Patrick Williams , Donald E Saunders , Kevin J Mcnamara , Michael D Witzeman , Nicholas Michael Westfall , Patrick P Grace , Spencer S Lee and Thomas P Rice . View institutional ownership trends .

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:CHE

Chemed (CHE) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free CHE Stock Alerts

$597.70

-6.47 (-1.07%)

(As of 04/18/2024 ET)

Compare

Today's Range: $595.69
▼
$605.18
50-Day Range: $571.74
▼
$650.70
52-Week Range: $492.84
▼
$654.62

Volume: 69,785 shs
Average Volume: 77,560 shs
Market Capitalization: $9.04 billion

P/E Ratio: 33.35
Dividend Yield: 0.27%
Price Target: $681.00

Get Chemed alerts:

Chemed MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 14.0% Upside
$681.00 Price Target
Short Interest: Healthy
3.06% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -0.33
Upright™ Environmental Score
News Sentiment: 0.85
Based on 4 Articles This Week
Insider Trading: Selling Shares
$10.18 M Sold Last Quarter
Proj. Earnings Growth: 9.28%
From $21.99 to $24.03 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.76 out of 5 stars

Medical Sector

48th out of 919 stocks

Home Health Care Services Industry

2nd out of 7 stocks

2.5

Analyst's Opinion

Consensus Rating
Chemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Chemed has only been the subject of 2 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.06% of the float of Chemed has been sold short.
Short Interest Ratio / Days to Cover
Chemed has a short interest ratio ("days to cover") of 5.7.
Change versus previous month
Short interest in Chemed has recently decreased by 4.40%, indicating that investor sentiment is improving.

3.3

Dividend Strength

Dividend Yield
Chemed has a dividend yield of 0.26%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Chemed has been increasing its dividend for 15 years.
Dividend Coverage
The dividend payout ratio of Chemed is 8.93%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Chemed will have a dividend payout ratio of 6.66% next year. This indicates that Chemed will be able to sustain or increase its dividend.

4.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Chemed has received a 80.32% net impact score from Upright. Chemed seems to create the most significant positive value in categories "Taxes", "Jobs", and "Meaning & joy". The positive contribution in the "Meaning & joy" impact category is mostly driven by its "Private hospice care", "Private home care for the elderly", and "Property water damage restoration" products. See details.
Environmental Sustainability
The Environmental Impact score for Chemed is -0.33.

2.1

News and Social Media Coverage

News Sentiment
Chemed has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Chemed this week, compared to 4 articles on an average week.
Search Interest
Only 3 people have searched for CHE on MarketBeat in the last 30 days. This is a decrease of -70% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $10,184,531.00 in company stock.
Percentage Held by Insiders
Only 4.03% of the stock of Chemed is held by insiders.
Percentage Held by Institutions
95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Chemed are expected to grow by 9.28% in the coming year, from $21.99 to $24.03 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Chemed is 33.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.12.
Price to Earnings Ratio vs. Sector
The P/E ratio of Chemed is 33.34, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 230.61.
Price to Earnings Growth Ratio
Chemed has a PEG Ratio of 2.45. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Chemed has a P/B Ratio of 8.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Chemed Stock (NYSE:CHE)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CHE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CHE Stock News Headlines

April 2, 2024 | insidertrades.com

Insider Selling: Chemed Co. (NYSE:CHE) EVP Sells 2,000 Shares of Stock

March 24, 2024 | insidertrades.com

Brian C. Judkins Sells 11,158 Shares of Chemed Co. (NYSE:CHE) Stock

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 23, 2024 | insidertrades.com

Insider Selling: Chemed Co. (NYSE:CHE) CFO Sells 2,650 Shares of Stock

April 17, 2024 | finance.yahoo.com

VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama

April 17, 2024 | businesswire.com

VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama

April 17, 2024 | americanbankingnews.com

Chemed (CHE) Set to Announce Quarterly Earnings on Wednesday

April 9, 2024 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: Chemed (CHE) and Alkermes (ALKS)

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 3, 2024 | finance.yahoo.com

Chemed Corporation (CHE) Rose 13% in Q4

April 1, 2024 | gurufocus.com

Chemed Corp Executive Vice President Spencer Lee Sells Company Shares

April 1, 2024 | finance.yahoo.com

Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25

March 22, 2024 | finance.yahoo.com

Chemed Corp VP and Chief Legal Officer Brian Judkins Sells 11,158 Shares

March 21, 2024 | finance.yahoo.com

Chemed Corporation's (NYSE:CHE) Stock Is Going Strong: Have Financials A Role To Play?

March 16, 2024 | finance.yahoo.com

CHE Apr 2024 670.000 call

March 16, 2024 | finance.yahoo.com

CHE Apr 2024 590.000 put

March 13, 2024 | markets.businessinsider.com

Chemed's Subsidiary To Purchase Hospice Assets Of Covenant Care For $85 Mln In Florida, Alabama

March 13, 2024 | bizjournals.com

Chemed's Vitas Healthcare plans $85M acquisition to expand Florida footprint

March 13, 2024 | finance.yahoo.com

VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

March 12, 2024 | msn.com

When is Passover? What you need to know ahead of the Jewish holiday

March 8, 2024 | businesswire.com

Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference

March 1, 2024 | finance.yahoo.com

Chemed Corporation (NYSE:CHE) Just Released Its Annual Results And Analysts Are Updating Their Estimates

February 29, 2024 | msn.com

Chemed Corporation (NYSE:CHE) Q4 2023 Earnings Call Transcript

February 29, 2024 | finance.yahoo.com

Chemed Full Year 2023 Earnings: In Line With Expectations

February 29, 2024 | finance.yahoo.com

Q4 2023 Chemed Corp Earnings Call

February 28, 2024 | seekingalpha.com

Chemed Q4 2023 Earnings Preview

February 27, 2024 | benzinga.com

Chemed: Q4 Earnings Insights

See More Headlines

Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/15 Dividend: 2/23/2024
Last Earnings: 2/27/2024
Dividend Payable: 3/15/2024
Today: 4/18/2024
Next Earnings (Confirmed): 4/24/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Home health care services
Sub-Industry: Health Care Services
Current Symbol: NYSE:CHE
CUSIP: 16359R10
CIK: 19584
Web: www.chemed.com
Phone: (513) 762-6690
Fax: 513-762-6590
Employees: 15,087
Year Founded: 1970

Price Target and Rating

Average Stock Price Target: $681.00
High Stock Price Target: $712.00
Low Stock Price Target: $650.00
Potential Upside/Downside: +13.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): $17.92
Trailing P/E Ratio: 33.37
Forward P/E Ratio: 27.19
P/E Growth: 2.45
Net Income: $272.51 million
Net Margins: 12.03%
Pretax Margin: 15.47%
Return on Equity: 32.29%
Return on Assets: 20.74%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.61
Quick Ratio: 1.57

Sales & Book Value

Annual Sales: $2.26 billion
Price / Sales: 3.99
Cash Flow: $24.08 per share
Price / Cash Flow: 24.83
Book Value: $73.55 per share
Price / Book: 8.13

Miscellaneous

Outstanding Shares: 15,120,000
Free Float: 14,508,000
Market Cap: $9.04 billion
Optionable: Optionable
Beta: 0.42

Social Links

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Kevin J. McNamara (Age 70)
CEO, President & Director
Comp: $5.84M
Mr. Michael D. Witzeman CPA (Age 53)
MBA, VP, Controller, Principal Accounting Officer & CFO
Comp: $1.15M
Mr. Spencer S. Lee (Age 68)
Executive Vice President
Comp: $1.65M
Mr. Thomas C. Hutton (Age 73)
VP & Director
Mr. Nicholas Michael Westfall (Age 45)
Executive Vice President
Comp: $2.5M
Ms. Lisa A. Reinhard
VP, Chief Administrative Officer & Secretary
Sherri Warner
Director of Investor Relations
Mr. Brian C. Judkins (Age 43)
VP, Secretary & Chief Legal Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CHE Stock Analysis - Frequently Asked Questions

Should I buy or sell Chemed stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CHE shares.
View CHE analyst ratings or view top-rated stocks.
What is Chemed's stock price target for 2024?: 2 Wall Street research analysts have issued twelve-month price targets for Chemed's stock. Their CHE share price targets range from $650.00 to $712.00. On average, they anticipate the company's share price to reach $681.00 in the next year. This suggests a possible upside of 14.0% from the stock's current price.
View analysts price targets for CHE or view top-rated stocks among Wall Street analysts.
How have CHE shares performed in 2024?: Chemed's stock was trading at $584.75 at the beginning of 2024. Since then, CHE stock has increased by 2.2% and is now trading at $597.42.
View the best growth stocks for 2024 here.
When is Chemed's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our CHE earnings forecast.
How can I listen to Chemed's earnings call?: Chemed will be holding an earnings conference call on Thursday, April 25th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.
How were Chemed's earnings last quarter?: Chemed Co. (NYSE:CHE) issued its earnings results on Tuesday, February, 27th. The company reported $6.60 earnings per share for the quarter, beating the consensus estimate of $6.25 by $0.35. The business had revenue of $585.90 million for the quarter, compared to the consensus estimate of $586.64 million. Chemed had a trailing twelve-month return on equity of 32.29% and a net margin of 12.03%. Chemed's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period last year, the business earned $5.39 earnings per share.
How often does Chemed pay dividends? What is the dividend yield for Chemed?: Chemed declared a quarterly dividend on Friday, February 16th. Stockholders of record on Monday, February 26th will be given a dividend of $0.40 per share on Friday, March 15th. This represents a $1.60 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date is Friday, February 23rd.
Read our dividend analysis for CHE.
Is Chemed a good dividend stock?: Chemed (NYSE:CHE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.26%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.93%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 6.66% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

What ETFs hold Chemed's stock?: ETFs with the largest weight of Chemed (NYSE:CHE) stock in their portfolio include Formidable Fortress ETF (KONG), VictoryShares THB Mid Cap ESG ETF (MDCP), First Trust Dorsey Wright Momentum & Low Volatility ETF (DVOL), Inspire Faithward Mid Cap Momentum ETF (GLRY), Opus Small Cap Value Plus ETF (OSCV), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), FIS Biblically Responsible Risk Managed ETF (PRAY) and ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL).
What guidance has Chemed issued on next quarter's earnings?: Chemed updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of 23.300-23.700 for the period, compared to the consensus earnings per share estimate of 23.010. The company issued revenue guidance of -.
What is Kevin J. McNamara's approval rating as Chemed's CEO?: 1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Chemed own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).
Who are Chemed's major shareholders?: Chemed's stock is owned by many different institutional and retail investors. Top institutional investors include Los Angeles Capital Management LLC (0.28%), Capital Insight Partners LLC (0.07%), MJP Associates Inc. ADV (0.01%), Wealth Enhancement Advisory Services LLC (0.01%), Ausbil Investment Management Ltd (0.01%) and LVW Advisors LLC (0.01%). Insiders that own company stock include Brian C Judkins, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice.
View institutional ownership trends.
How do I buy shares of Chemed?: Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CHE) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Chemed (CHE) Stock Price, News & Analysis

Chemed MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Chemed Stock (NYSE:CHE)

CHE Stock Price History

CHE Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

CHE Stock Analysis - Frequently Asked Questions

Overall MarketRank^™